Tag: spine

BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis

Sustained symptom relief in patients with psoriatic arthritis: Achievement of the stringent ACR50 endpoint was sustained at three years by 53.2% and 55.2% of patients...

Home Healthcare Market Share Worth $666.91 billion, Globally, by 2030 – Exclusive Study by The Research Insights

CHICAGO, June 11, 2025 /PRNewswire/ -- The Global Home Healthcare Market share is projected to be valued at USD 420.79 billion in 2024 and reach USD...

Safe Group announces FDA 510(k) clearance for SpineUp’s Frida solution

Safe Group announces FDA 510(k) clearance for SpineUp's Frida solution

Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System

CARLSBAD, CALIFORNIA, June 10, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a pioneer in innovative spinal solutions, proudly announces that its proprietary SiLO™ Sacroiliac (SI) Joint Fusion System has been successfully used in over 2,500 procedures across the United States. This major milestone underscores the company’s accelerating growth and increasing adoption of its minimally invasive technology by surgeons nationwide.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsSpine

Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

MimiSilk Marks 12 Years of Advanced Care with New Product Launches and Anniversary Sale

Tag: spine

BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis

Home Healthcare Market Share Worth $666.91 billion, Globally, by 2030 – Exclusive Study by The Research Insights

Safe Group announces FDA 510(k) clearance for SpineUp’s Frida solution

Aurora Spine Surpasses Milestone of 2,500 Procedures Using SiLO™ SI Joint Fusion System

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us